Filing Flows › Xylem (XYL) › Q2 2026
Xylem (XYL) Q2 2026 earnings results (second quarter 2026)
10-Q filed Jul 28, 2026
Xylem (XYL) reported revenue of $2.3B for the second quarter 2026 (Q2 2026), +2% from a year earlier and +10% from the quarter before. Operating margin was 16.7%, net earnings $263M (11.3% of revenue).
Xylem, Q2 2026: revenue $2.3B (+2% year over year), operating margin 16.7%, net earnings $263M, operating cash flow $290M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.3B | +10% | +2% |
| Gross profit | $963M | +20% | +8% |
| Operating profit | $390M | +60% | +28% |
| Net earnings | $263M | +36% | +16% |
| Operating cash flow | $290M | +169% | -5% |
| Free cash flow | $201M | 11× | -3% |
What changed
Revenue was $2.3B in Q2 2026, up 2% year over year and up 10% from the previous quarter. Revenue from products was the largest line at 84% of revenue. Revenue from products added $0.04B year over year (up 2%), 120% of the total change. Revenue from services declined 2%.
Gross margin was 41.2%, up 2.5 points from Q2 2025. Operating profit was $0.39B, a 16.7% margin (up 3.4 points year over year). Of the extra revenue versus Q2 2025, 243% reached operating profit, above the 13% margin then. Operating expenses fell 2% while revenue rose 2%. Net earnings were $0.26B, up 16% year over year. The effective tax rate was 28.3%.
Operating cash flow was $0.29B (down 5% year over year), 111% of net earnings. Non-cash charges added back $0.14B of depreciation and amortization and $0.01B of share-based compensation. Working capital and other items used $0.12B. Capital expenditures of $0.09B left free cash flow of $0.20B.
Questions
What was Xylem's revenue in the second quarter 2026?
Xylem (XYL) reported revenue of $2.3B for the second quarter 2026 (Q2 2026), +2% from a year earlier and +10% from the quarter before.
Was Xylem profitable in the second quarter 2026?
Operating profit was $390M (16.7% of revenue) and net earnings $263M.
Source: Xylem 10-Q on SEC EDGAR.